Cell4Pharma
Research - Oss, North Brabant, Netherlands
Cell4Pharma Employees
Cell4Pharma Details
We envision a world without a risk for renal toxicity for compounds entering clinical stages of drug development.Cell4Pharma aims to reduce the failure rate in late clinical stages due to renal tox below 3% market wide within the next 10 years. Without the use of animal experimentation.This ambition is supported by our human renal cell line ciPTEC validated during extensive collaborations with the pharmaceutical industry. More than 10 years of research lead to the development of robust cell-based assays focusing on the detection of highly specific biomarkers for renal toxicity.
Cell4Pharma Technologies
Captcha
reCAPTCHA
Load Balancers
Apache
CMS
WordPress.org
Fonts
Google Font API
Other
Mobile Friendly
Analytics and Tracking
Google Analytics